Regeneron
-$8.52 (-1.46%) Today
$0.00 (0.00%) As of 9:10 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Regeneron and other ETFs, options, and stocks.
About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.
CEO
Leonard S. Schleifer
Employees
9,123
Headquarters
Tarrytown, New York
Founded
1988
REGN Key Statistics
Market Cap
61.22B
Price-Earnings Ratio
16.50
Dividend Yield
—
Average Volume
573.38K
High Today
$583.27
Low Today
$572.96
Open Price
$581.42
Volume
775.38K
52 Week High
$660.00
52 Week Low
$441.00
REGN News
Reuters3h
FDA okays Regeneron COVID-19 antibody as preventive in high-risk settings
The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Br
Analyst Ratings
62%
of 26 ratings
Buy
61.5%
Hold
38.5%
Sell
0%
REGN Earnings
$0.00
$3.30
$6.59
$9.89
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, Pre-Market
